SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-003754
Filing Date
2023-02-22
Accepted
2023-02-22 16:10:12
Documents
12
Period of Report
2023-02-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20230215.htm   iXBRL 8-K 77949
  Complete submission text file 0000950170-23-003754.txt   195224

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rkda-20230215_lab.xml EX-101.LAB 13360
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rkda-20230215.xsd EX-101.SCH 2463
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rkda-20230215_pre.xml EX-101.PRE 9839
6 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20230215_htm.xml XML 4672
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

IRS No.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 23653191
SIC: 0100 Agricultural Production-Crops